½ÃÀ庸°í¼­
»óǰÄÚµå
1351238

¼¼°èÀÇ ¾×ü ÷°¡Á¦ ¼ºÀå ±âȸ

Global Liquid Dosage Excipients Growth Opportunities

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Frost & Sullivan | ÆäÀÌÁö Á¤º¸: ¿µ¹® 82 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ȯÀÚ Áß½ÉÀÇ ºñ°æ±¸Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ¼ºÀå ÀáÀç·ÂÀ» °¡¼ÓÈ­

¾×»ó Åõ¿©¿ë ºÎÇüÁ¦¿¡ ´ëÇÑ ¼¼°è ¿¬±¸´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µî ÁÖ¿ä Áö¿ª ½ÃÀå¿¡¼­ 2022³âºÎÅÍ 2030³â±îÁö °æ±¸¿ë ¾×ü ¹× ºñ°æ±¸¿ë ºÎÇüÁ¦ ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ Æò°¡ÇÕ´Ï´Ù. °æ±¸¿ë ¾×ü ºÎÇüÁ¦ ½ÃÀåÀº °¨¹Ì·á, pH Á¶ÀýÁ¦ ¹× ¿ÏÃæÁ¦, ½ÀÀ±Á¦ ¹× °¡¿ëÈ­Á¦, ±âŸ(ų·¹ÀÌÆ®Á¦, ¹æºÎÁ¦, Çâ·á µî)¿Í °°Àº ´Ù¾çÇÑ ºÎ¹®¿¡ ´ëÇÑ ÁúÀû ¹× Á¤·®Àû ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. °æ±¸¿ë ¾×ü Á¦Á¦ ºÎ¹®Àº ¼Ò¾Æ ¹× ³ëÀÎÀÇ ´Ù¾çÇÑ Áúº´À» Ä¡·áÇϱâ À§ÇÑ ½Å¾à ½ÂÀÎÀÌ Áõ°¡Çϸ鼭 ¿¹Ãø ±â°£ µ¿¾È ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ºñ°æ±¸¿ë ºÎÇüÁ¦ ¼¼°è ½ÃÀå Á¶»ç ºÎ¹®¿¡´Â °¡¿ëÈ­Á¦, ¿ÏÃæÁ¦, º¸Á¸Á¦, ±âŸ(°­ÀåÁ¦, ų·¹ÀÌÆ®Á¦, Ç×»êÈ­Á¦, Áõ·®Á¦ µî)°¡ Æ÷ÇԵ˴ϴÙ. ¾Ï, Èñ±Í Áúȯ, ½ÉÇ÷°ü Áúȯ°ú °°Àº Áúº´À» Ä¡·áÇϱâ À§ÇÑ »ý¹°ÇÐÀû Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È ºñ°æ±¸ ºÎÇüÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀÌ µÉ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Àü·«Àû °úÁ¦

  • ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?
  • The Strategic Imperative 8(TM)
  • ¾×ü ÷°¡Á¦ ¾÷°èÀÇ Àü·«Àû Áß¿ä °úÁ¦ »óÀ§ 3°³ ÀÓÆÑÆ®
  • ¼ºÀå ±âȸ°¡ Growth Pipeline Engine(TM)À» ÁöÁöÇÑ´Ù

¼ºÀå ±âȸ ºÐ¼®

  • ºÐ¼® ¹üÀ§
  • ¼¼ºÐÈ­
  • ½ÃÀå Á¤ÀÇ-ÀǾàǰ ÷°¡Á¦
  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå Á¤ÀÇ-±âŸÀÇ ÁÖ¿ä Á¤ÀÇ
  • ÁÖ¿ä °æÀï»ç
  • ¼¼°èÀÇ ÀǾàǰ ½ÃÀå °³¿ä
  • ¼¼°èÀÇ ÀǾàǰ ½ÃÀå µ¿Çâ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼ºÀå ¾ïÁ¦ ºÐ¼®
  • ¹ë·ùüÀÎ
  • ¼ºÀå ÁöÇ¥
  • ¿¹Ãø °¡Á¤
  • ¸ÅÃâ ¿¹Ãø
  • ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • À¯Çüº° ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº° ¸ÅÃâ ¿¹Ãø
  • À¯Çüº°¡¤Áö¿ªº° ¸ÅÃâ ¿¹Ãø ºÐ¼®
  • °æÀï ȯ°æ
  • °æÀï »ýŰè
  • °æÀï º¥Ä¡¸¶Å·
  • ½ÃÀå Ȱµ¿-½ÅÁ¦Ç° ¹ßÇ¥, M&A, ÆÄÆ®³Ê½Ê, »ç¾÷ È®´ë(2020-2023³â)
  • °¡°Ý µ¿Çâ°ú ¿¹Ãø ºÐ¼®

¼ºÀå ±âȸ ºÐ¼® - ±¸°­¿ë ¾×ü ÷°¡Á¦

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ°ú ¿¹Ãø
  • À¯Çüº° ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº° ¸ÅÃâ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®
  • À¯Çüº° ¿¹Ãø ºÐ¼®
  • Áö¿ªº° ¿¹Ãø ºÐ¼®

¼ºÀå ±âȸ ºÐ¼® - ºñ°æ±¸ ÷°¡Á¦

  • ¼ºÀå ÁöÇ¥
  • ¸ÅÃâ ¿¹Ãø
  • À¯Çüº° ¸ÅÃâ ¿¹Ãø
  • Áö¿ªº° ¸ÅÃâ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®
  • À¯Çüº° ¿¹Ãø ºÐ¼®
  • Áö¿ªº° ¿¹Ãø ºÐ¼®

¼ºÀå ±âȸ À¯´Ï¹ö½º

  • ¼ºÀå ±âȸ 1 - ½Å±Ô ºÎÇüÁ¦ °³¹ßÀ» À§ÇÑ µ¶¸³ÇÑ ½ÂÀÎ °æ·ÎÀÇ Çʿ伺
  • ¼ºÀå ±âȸ 2 - mRNA ±â¹Ý Ä¡·áÁ¦
  • ¼ºÀå ±âȸ 3 - È¿°úÀûÀÎ ¼Ò¾Æ¿ë ¾à¹°Àü´Þ¿¡ ´ëÇÑ ¿ä±¸
  • ¼ºÀå ±âȸ 4 - ÁÖ»çÁ¦ ½ºÆä¼ÈƼ¡¤Á¦³×¸¯ À» À§ÇÑ Â÷º°È­µÈ ´É·Â

´ÙÀ½ ½ºÅÜ

  • ´ÙÀ½ ½ºÅÜ
  • ¿Ö Áö±Ý ÇÁ·Î½ºÆ®Àΰ¡?
  • º°Áö ¸®½ºÆ®
  • ¸éÃ¥»çÇ×
ksm 23.10.30

Demand for Patient-centric Parenteral Formulation Accelerates Growth Potential

The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Liquid Dosage Excipient Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation
  • Market Definitions-Pharmaceutical Excipients
  • Market Definitions
  • Market Definitions-Other Key Definitions
  • Key Competitors
  • Global Pharmaceutical Market Overview
  • Global Pharmaceutical Market Trends
  • Growth Drivers
  • Growth Drivers Analysis
  • Growth Restraints
  • Growth Restraint Analysis
  • Value Chain
  • Growth Metrics
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Analysis
  • Revenue Forecast by Type
  • Revenue Forecast by Region
  • Forecast Analysis by Type and Region
  • Competitive Environment
  • Competitive Ecosystem
  • Competitive Benchmarking
  • Market Activities-New Product Launches, M&As, Partnerships, and Expansions, 2020-2023
  • Pricing Trends and Forecast Analysis

Growth Opportunity Analysis-Oral Liquid Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Type
  • Revenue Forecast by Region
  • Forecast Analysis
  • Forecast Analysis by Type
  • Forecast Analysis by Region

Growth Opportunity Analysis-Parenteral Excipients

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Type
  • Revenue Forecast by Region
  • Forecast Analysis
  • Forecast Analysis by Type
  • Forecast Analysis by Region

Growth Opportunity Universe

  • Growth Opportunity 1-Need for an Independent Approval Pathway for Novel Excipient Development
  • Growth Opportunity 2-mRNA-based Therapeutics
  • Growth Opportunity 3-Need for Effective Pediatric Drug Delivery Solutions
  • Growth Opportunity 4-Differentiated Capabilities for Injectable Specialty Generics

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦